Abstract
Objectives: A few CLIA automated immunoassays for the recognition of anti S1-RBD SARS-CoV-2 antibodies have recently been placed on the market. Prelim......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
